Although AML cell engraftment was detected in all secondary NSG recipient mice, engraftment levels were significantly higher in mice engrafted with CD34+ than CD34− cells in peripheral blood, spleen, and BM (Fig. 2c–e). This evidence concerns the gene CD34 and acute myeloid leukemia.